サマリー

神経障害性疼痛治療の世界市場 2024-2028
神経障害性疼痛治療市場は、2023-2028年に5億8,405万米ドルで成長し、予測期間中のCAGRは10.96%で加速すると予測されます。当レポートでは、神経障害性疼痛治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経障害性疼痛の患者数が多いこと、糖尿病性神経障害性疼痛の治療薬の開発に注目が集まっていること、ジェネリック医薬品の浸透が進んでいることなどが市場を牽引しています。
Technavioの神経障害性疼痛治療市場は以下のようにセグメント化されている：
適応症別
- 糖尿病性神経障害
- 化学療法による神経障害性疼痛
- 帯状疱疹後神経痛
- その他
流通チャネル別
- 小売薬局
- 病院薬局
- オンライン薬局
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、神経障害性疼痛治療用局所パッチの開発が市場ダイナミクスを変化させることが、今後数年間の神経障害性疼痛治療市場の成長を促進する主要な理由の1つであると特定している。また、新興国への注目の高まりや、肥満と内分泌疾患との関連は、市場の大きな需要につながるでしょう。
本レポートでは、神経障害性疼痛治療市場について以下の領域をカバーしています：
- 神経障害性疼痛治療市場規模
- 神経障害性疼痛治療市場予測
- 神経障害性疼痛治療市場産業分析
本レポートでは、神経障害性疼痛治療市場の主要ベンダーであるAbbott Laboratories、Alfasigma Spa、Astellas Pharma Inc.、AstraZeneca Plc、Baxter International Inc.、Biogen Inc.、Bristol Myers Squibb Co.Ltd.、Dr Reddys Laboratories Ltd.、Eli Lilly and Co.、Endo International Plc、GlaxoSmithKline Plc、Johnson and Johnson、Mallinckrodt Plc、Neuracle Lifesciences Pvt. Ltd.、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Vertex Pharmaceuticals Inc.、VistaGen Therapeutics Inc.また、神経障害性疼痛治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neuropathy-pain-treatment-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global neuropathy pain treatment market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global neuropathy pain treatment market 2018 - 2022 ($ million)
o 4.2 Indication Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Indication
o 6.1 Market segments
o Exhibit 30: Chart on Indication - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Indication - Market share 2023-2028 (%)
o 6.2 Comparison by Indication
o Exhibit 32: Chart on Comparison by Indication
o Exhibit 33: Data Table on Comparison by Indication
o 6.3 Diabetic neuropathy - Market size and forecast 2023-2028
o Exhibit 34: Chart on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
o 6.4 Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028
o Exhibit 38: Chart on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
o 6.5 Postherpetic neuralgia - Market size and forecast 2023-2028
o Exhibit 42: Chart on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
o 6.6 Others - Market size and forecast 2023-2028
o Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Indication
o Exhibit 50: Market opportunity by Indication ($ million)
o Exhibit 51: Data Table on Market opportunity by Indication ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 54: Chart on Comparison by Distribution Channel
o Exhibit 55: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 7.4 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 60: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 68: Market opportunity by Distribution Channel ($ million)
o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 UK - Market size and forecast 2023-2028
o Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories - Overview
o Exhibit 120: Abbott Laboratories - Business segments
o Exhibit 121: Abbott Laboratories - Key news
o Exhibit 122: Abbott Laboratories - Key offerings
o Exhibit 123: Abbott Laboratories - Segment focus
o 12.4 Astellas Pharma Inc.
o Exhibit 124: Astellas Pharma Inc. - Overview
o Exhibit 125: Astellas Pharma Inc. - Product / Service
o Exhibit 126: Astellas Pharma Inc. - Key news
o Exhibit 127: Astellas Pharma Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 128: AstraZeneca Plc - Overview
o Exhibit 129: AstraZeneca Plc - Product / Service
o Exhibit 130: AstraZeneca Plc - Key news
o Exhibit 131: AstraZeneca Plc - Key offerings
o 12.6 Baxter International Inc.
o Exhibit 132: Baxter International Inc. - Overview
o Exhibit 133: Baxter International Inc. - Business segments
o Exhibit 134: Baxter International Inc. - Key news
o Exhibit 135: Baxter International Inc. - Key offerings
o Exhibit 136: Baxter International Inc. - Segment focus
o 12.7 Biogen Inc.
o Exhibit 137: Biogen Inc. - Overview
o Exhibit 138: Biogen Inc. - Product / Service
o Exhibit 139: Biogen Inc. - Key offerings
o 12.8 Bristol Myers Squibb Co.
o Exhibit 140: Bristol Myers Squibb Co. - Overview
o Exhibit 141: Bristol Myers Squibb Co. - Product / Service
o Exhibit 142: Bristol Myers Squibb Co. - Key news
o Exhibit 143: Bristol Myers Squibb Co. - Key offerings
o 12.9 Daiichi Sankyo Co. Ltd.
o Exhibit 144: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 145: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 146: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 147: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.10 Dr Reddys Laboratories Ltd.
o Exhibit 148: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 149: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 150: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 151: Dr Reddys Laboratories Ltd. - Segment focus
o 12.11 Eli Lilly and Co.
o Exhibit 152: Eli Lilly and Co. - Overview
o Exhibit 153: Eli Lilly and Co. - Product / Service
o Exhibit 154: Eli Lilly and Co. - Key news
o Exhibit 155: Eli Lilly and Co. - Key offerings
o 12.12 Endo International Plc
o Exhibit 156: Endo International Plc - Overview
o Exhibit 157: Endo International Plc - Business segments
o Exhibit 158: Endo International Plc - Key news
o Exhibit 159: Endo International Plc - Key offerings
o Exhibit 160: Endo International Plc - Segment focus
o 12.13 Johnson and Johnson
o Exhibit 161: Johnson and Johnson - Overview
o Exhibit 162: Johnson and Johnson - Business segments
o Exhibit 163: Johnson and Johnson - Key news
o Exhibit 164: Johnson and Johnson - Key offerings
o Exhibit 165: Johnson and Johnson - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 166: Pfizer Inc. - Overview
o Exhibit 167: Pfizer Inc. - Product / Service
o Exhibit 168: Pfizer Inc. - Key news
o Exhibit 169: Pfizer Inc. - Key offerings
o 12.15 Sanofi
o Exhibit 170: Sanofi - Overview
o Exhibit 171: Sanofi - Business segments
o Exhibit 172: Sanofi - Key news
o Exhibit 173: Sanofi - Key offerings
o Exhibit 174: Sanofi - Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 175: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 176: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 177: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.17 VistaGen Therapeutics Inc.
o Exhibit 178: VistaGen Therapeutics Inc. - Overview
o Exhibit 179: VistaGen Therapeutics Inc. - Product / Service
o Exhibit 180: VistaGen Therapeutics Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 181: Inclusions checklist
o Exhibit 182: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 183: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 184: Research methodology
o Exhibit 185: Validation techniques employed for market sizing
o Exhibit 186: Information sources
o 13.5 List of abbreviations
o Exhibit 187: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global neuropathy pain treatment market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Indication - Market share 2023-2028 (%)
Exhibits31: Data Table on Indication - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Indication
Exhibits33: Data Table on Comparison by Indication
Exhibits34: Chart on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Indication ($ million)
Exhibits51: Data Table on Market opportunity by Indication ($ million)
Exhibits52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits53: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Distribution Channel ($ million)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories - Overview
Exhibits120: Abbott Laboratories - Business segments
Exhibits121: Abbott Laboratories - Key news
Exhibits122: Abbott Laboratories - Key offerings
Exhibits123: Abbott Laboratories - Segment focus
Exhibits124: Astellas Pharma Inc. - Overview
Exhibits125: Astellas Pharma Inc. - Product / Service
Exhibits126: Astellas Pharma Inc. - Key news
Exhibits127: Astellas Pharma Inc. - Key offerings
Exhibits128: AstraZeneca Plc - Overview
Exhibits129: AstraZeneca Plc - Product / Service
Exhibits130: AstraZeneca Plc - Key news
Exhibits131: AstraZeneca Plc - Key offerings
Exhibits132: Baxter International Inc. - Overview
Exhibits133: Baxter International Inc. - Business segments
Exhibits134: Baxter International Inc. - Key news
Exhibits135: Baxter International Inc. - Key offerings
Exhibits136: Baxter International Inc. - Segment focus
Exhibits137: Biogen Inc. - Overview
Exhibits138: Biogen Inc. - Product / Service
Exhibits139: Biogen Inc. - Key offerings
Exhibits140: Bristol Myers Squibb Co. - Overview
Exhibits141: Bristol Myers Squibb Co. - Product / Service
Exhibits142: Bristol Myers Squibb Co. - Key news
Exhibits143: Bristol Myers Squibb Co. - Key offerings
Exhibits144: Daiichi Sankyo Co. Ltd. - Overview
Exhibits145: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits146: Daiichi Sankyo Co. Ltd. - Key news
Exhibits147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits148: Dr Reddys Laboratories Ltd. - Overview
Exhibits149: Dr Reddys Laboratories Ltd. - Business segments
Exhibits150: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits151: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits152: Eli Lilly and Co. - Overview
Exhibits153: Eli Lilly and Co. - Product / Service
Exhibits154: Eli Lilly and Co. - Key news
Exhibits155: Eli Lilly and Co. - Key offerings
Exhibits156: Endo International Plc - Overview
Exhibits157: Endo International Plc - Business segments
Exhibits158: Endo International Plc - Key news
Exhibits159: Endo International Plc - Key offerings
Exhibits160: Endo International Plc - Segment focus
Exhibits161: Johnson and Johnson - Overview
Exhibits162: Johnson and Johnson - Business segments
Exhibits163: Johnson and Johnson - Key news
Exhibits164: Johnson and Johnson - Key offerings
Exhibits165: Johnson and Johnson - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Sanofi - Overview
Exhibits171: Sanofi - Business segments
Exhibits172: Sanofi - Key news
Exhibits173: Sanofi - Key offerings
Exhibits174: Sanofi - Segment focus
Exhibits175: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits176: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits177: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits178: VistaGen Therapeutics Inc. - Overview
Exhibits179: VistaGen Therapeutics Inc. - Product / Service
Exhibits180: VistaGen Therapeutics Inc. - Key offerings
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations